SML3130
SHetA2
≥98% (HPLC)
别名:
1-(4-Nitrophenyl)-3-(2,2,4,4-tetramethylthiochroman-6-yl)thiourea, N-(3,4-Dihydro-2,2,4,4-tetramethyl-2H-1-benzothiopyran-6-yl)-N′-(4-nitrophenyl)thiourea, NSC 726189, NSC-726189, NSC726189, Sulfur Heteroarotinoid A2
登录 查看组织和合同定价。
选择规格
变更视图
关于此项目
Assay:
≥98% (HPLC)
Form:
powder
Quality Segment
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
SMILES string
S=C(NC1=CC=C2SC(C)(CC(C)(C)C2=C1)C)NC(C=C3)=CC=C3[N+]([O-])=O
InChI
1S/C20H23N3O2S2/c1-19(2)12-20(3,4)27-17-10-7-14(11-16(17)19)22-18(26)21-13-5-8-15(9-6-13)23(24)25/h5-11H,12H2,1-4H3,(H2,21,22,26)
InChI key
FWWKIYPMUZVMQG-UHFFFAOYSA-N
Biochem/physiol Actions
Orally available chemopreventive fexible heteroarotinoid (Flex-Het) that induces cancer apoptosis in cultures and in vivo independent of retinoic acid receptor (RAR).
SHetA2 is an orally available chemopreventive fexible heteroarotinoid (Flex-Het) that inhibits cancer growth in cultures (OVCAR-3/SK-OV-3/Caov-3 GI50 = 3.9/4.1/7.0 μM) and in vivo (60-100 mg/kg SiHa xenograft mice) via apoptosis induction independent of retinoic acid receptor (RAR). SHetA2 is reported to bind heatshock proteins HSPA5 (GRP78, BiP), HSPA8 (HSC70, HSP73, HSPA10), HSPA9 (GRP75), resulting in cyclin D1 degradation.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable